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Melanocyte stem cells in the bulge area of hair folli-
cles are responsible for hair pigmentation, and
defects in them cause hair graying. Here we describe
the process of melanocyte stem cell entry into the
quiescent state and show that niche-derived trans-
forming growth factor b (TGF-b) signaling plays
important roles in this process. In vitro, TGF-b not
only induces reversible cell cycle arrest, but also
promotes melanocyte immaturity by downregulating
MITF, the master transcriptional regulator of melano-
cyte differentiation, and its downstream melano-
genic genes. In vivo, TGF-b signaling is activated in
melanocyte stem cells when they reenter the quies-
cent noncycling state during the hair cycle and this
process requires Bcl2 for cell survival. Furthermore,
targeted TGF-b type II receptor (TGFbRII) deficiency
in the melanocyte lineage causes incomplete mainte-
nance of melanocyte stem cell immaturity and results
in mild hair graying. These data demonstrate that the
TGF-b signaling pathway is one of the key niche
factors that regulate melanocyte stem cell immaturity
and quiescence.
INTRODUCTION
Somatic stem cells are generally present in a special cellular
organization called the niche (Watt and Hogan, 2000; Li and
Xie, 2005). In a niche, stem cells are able to self-renew with
high probability and they divide infrequently. The important roles
of the niche for stem cell maintenance have been demonstrated
in several stem cell systems (Scadden, 2006; Nystul and Spra-
dling, 2006; Nishimura et al., 2002). Genetic studies have
revealed a variety of genes essential for stem cell regulation,130 Cell Stem Cell 6, 130–140, February 5, 2010 ª2010 Elsevier Inc.especially in Drosophila germline stem cells, mouse hematopoi-
etic stem cells, and epidermal stem cells. However, the intricate
molecular mechanisms that underlie maintenance of stem cells
by the surrounding niche environment are not well understood
in many vertebrate stem cell systems, at least partly because
of the difficulties in identifying and visualizing stem cells and their
niches in tissue structures.
Melanocyte stem cells have been identified in a distinct tissue
structure called the bulge (Nishimura et al., 2002), an area that is
mostly populated by follicular keratinocyte stem cells (Cotsarelis,
2006; Tumbar et al., 2004) and that lies on the basement
membrane to which the arrector pili muscle is attached. Our pre-
vious study demonstrated that the niche plays a dominant role
in melanocyte stem cell fate determination (Nishimura et al.,
2002). Indeed, the melanocyte stem cell compartment becomes
regionally segregated away from the hair matrix where the ampli-
fying and differentiating cell compartment resides after stem cell
division (a schematic is shown in Figure 1L). Thus the different
fates of the stem cell compartment and the amplifying and
differentiating compartments can be explained by stem cell
niche-specific cues in the bulge area and/or by activating signals
from the maturing cell niche, the hair matrix in hair follicles.
We previously identified two genes, Bcl2 and Mitf, that are
essential for melanocyte stem cell maintenance (Nishimura
et al., 2005). Melanocyte stem cells are usually maintained in
a quiescent (noncycling) state and are activated only at early
anagen (the growing phase) to undergo stem cell division. Bcl2
is essential for the survival of melanocyte stem cells at the
stage where they return to the quiescent state (Nishimura
et al., 2005). Mitf, the master transcriptional regulator of melano-
cyte development (Steingrı´msson et al., 2004; Levy et al., 2006),
is also essential for melanocyte stem cell maintenance by pre-
venting premature differentiation/pigmentation of melanocyte
stem cells in the niche (Nishimura et al., 2005). However,
extrinsic signals that act dominantly upon the melanocyte stem
cell niche have not been thus far identified.
Transforming growth factor-beta (TGF-b) is a multifunctional
cytokine that plays important roles in the induction of apoptosis,
Figure 1. The Process of Melanocyte Stem Cell Entry into a Dormant State
(A–H) Morphological changes of bulge melanoblasts and the downregulation of melanogenic genes at the final stage of hair follicle morphogenesis.
(A and B) Expression of MITF (green) and DCT (red) by bulge melanoblasts at stages 6 and 8, respectively.
(C–F) TRP1 (red) and KIT (green) expression in follicles from stage 5 to stage 8 (X400).
(G and H) Immunostaining of tyrosinase (red) and PAX3 (green) (X400).
(I and J) Immunostaining of early anagen follicle (I) and midanagen follicle (J) for Dct-lacZ (red) and MITF (green) (X400). Note the significant downregulation of
MITF and DCT by bulge melanoblasts by midanagen.
(K) Immunostaining of hair follicles of different stages for Ki67 (red) and Pax3 (green) (X200).
(L) Schematic of melanocyte stem cell development and their entry into a dormant state after development and during the hair cycle.
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Role for TGF-b in Melanocyte Stem Cell Maintenancecellular growth arrest, and other physiological and pathological
responses (Siegel and Massague´, 2003; Massague´ and Gomis,
2006). The role of TGF-b in stem cell quiescence has been sug-
gested in hematopoietic stem cells (Batard et al., 2000; Larsson
et al., 2003; Karlsson et al., 2007; Yamazaki et al., 2007), prostate
stem cells (Kim et al., 2004), and neural stem cells (Falk et al.,
2008) with compelling supportive evidence, although in vivo
evidence for the indispensability of TGF-b in stem cell mainte-
nance is still lacking. There are three mammalian isoforms of
TGF-b (1, 2, and 3) that signal through type I and type II TGF-b
receptors. Signaling can occur only in the presence of both typesCof receptors and their downstream intracellular mediators
(Smad2/3) that subsequently enter the nucleus where transcrip-
tion of their target genes is regulated. In the skin, TGF-bs are
expressed by the regressing hair follicle strand and their role in
hair follicle regression through the induction of apoptosis has
been well established (Foitzik et al., 2000; Soma et al., 2003).
Recent gene expression profiling studies of epidermal label-
retaining keratinocytes in the hair follicle bulge region suggest
that TGF-b signaling is active in hair follicle keratinocyte stem
cells (Tumbar et al., 2004) that reside together in the niche
microenvironment with melanocyte stem cells. The significantell Stem Cell 6, 130–140, February 5, 2010 ª2010 Elsevier Inc. 131
Figure 2. Activated TGF-b Signaling in the
Bulge Area at the Time of Melanocyte
Stem Cell Entry into the Dormant State
(A and B) TGF-b1 (red) expression in the pelage
hair follicle (A) and in the sensory hair follicle at
stage 7 (B). Double arrows indicate bulge (Bg).
(C) Immunostaining for phospho-Smad2 (green).
(D) Schematic representation of a mouse pelage
hair follicle.
(E–G) Localization of phospho-Smad2 (green)- in
Dct-lacZ (red)-expressing cells (arrows) in the
bulge area of stage 6–8 follicles (X600).
Abbreviations: P, permanent portion; T, transient
portion; Sg, sebaceous gland; Bg, bulge area
(double arrows in A–C); Bb, hair bulb; APM, arrec-
tor pili muscle; HS, hair shaft; ORS, outer root
sheath; M, hair matrix; FP, follicular papilla.
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Role for TGF-b in Melanocyte Stem Cell Maintenanceexpression of TGF-b-induced factors in the bulge area and the
growth inhibitory functions of TGF-b (Massague´ and Gomis,
2006) suggested to us that TGF-b is a candidate niche-derived
factor that might transmit quiescence signals to melanocyte
stem cells. To examine this, we tested the effects of TGF-b on
melanocytes in vitro and in vivo and demonstrate that TGF-b
signaling plays dual roles in melanocyte stem cell maintenance
through the inhibition of stem cell differentiation in the stem
cell niche and the induction of stem cell quiescence.
RESULTS
Melanocyte Stem Cell Entry into the Dormant State
Melanoblasts that colonize the hair follicle bulge are inactivated
at the final stage of hair follicle morphogenesis and thereafter
function as the melanocyte stem cell population (Nishimura
et al., 2002, 2005). That population is activated at the beginning
of each hair regeneration cycle (early anagen) to self-renew but is
inactivated again by midanagen. Thus, we hypothesized that
melanocyte stem cells enter the quiescent (noncycling) inacti-
vated state in response to external cues from the stem cell niche
at a particular stage. To test this hypothesis and to understand
the mechanism of stem cell entry into the dormant noncycling
state, we first examined changes in morphology and expression
of melanogenic genes and the cell cycle progression marker
Ki67 in melanocyte stem cells after colonization of the hair
follicle bulge. As shown in Figures 1A–1H and Figure S1 (avail-
able online), profound downregulation of melanogenic factors
including MITF (Figures 1A and 1B; Figure S1A), tyrosinase-
related protein 1 (TRP1) (Figures 1C–1F; Figure S1B), tyrosinase
(Figures 1G and 1H; Figure S1C), and dopachrome tautomerase
(DCT) (Figures 1A and 1B; Figure S1A) were detected by the end
of hair follicle morphogenesis (stage 8). Expression of PAX3 and132 Cell Stem Cell 6, 130–140, February 5, 2010 ª2010 Elsevier Inc.KIT were maintained longer (Figures
1C–1H; Figure S1B) but were subse-
quently downregulated gradually (data
not shown). We then found that these
events are preceded by a loss of Ki67
expression at approximately stage 5
(standardized hair follicle stages based
on Paus et al. [1999]) of hair folliclemorphogenesis (Figure 1K) and the loss of BrdU incorporation
by melanocyte stem cells from this stage (Nishimura et al.,
2002, and data not shown). Interestingly, downregulation of
Ki67 and melanogenic gene expression at the time of stem cell
entry into quiescence was similarly found in the following cycles
(Figures 1I, 1J, and 1L and data not shown).
TGF-b Signaling in Melanocyte StemCells at Their Entry
into the Dormant State
To examine the possible involvement of TGF-b in the process
of stem cell entry into the noncycling state (stem cell
dormancy), we first examined the expression of TGF-bs in
hair follicles at different follicle stages. As shown in Figures
2A and 2B, TGF-b1/2 expression was found in the bulge area
of follicles starting at around stage 6 and was significantly
high at stage 7 (Figures 2A and 2B). Smad2, which is directly
phosphorylated by TGF-b receptors, was also found in
transgenically tagged (LacZ+) immature melanoblasts and
surrounding keratinocytes in the bulge area (Figures 2C and
2E–2G). The phospho-Smad2 signal was strong in those imma-
ture melanoblasts in the bulge area of stage 6 and 7 follicles
and was then gradually downregulated at stage 8 (Figures 2F
and 2G). Interestingly, TGF-b1/2 expression was upregulated
again after stem cell division and was maintained in the bulge
area during anagen, followed by a gradual downregulation
from catagen to telogen (data not shown). On the other hand,
the expression of TGF-b1/2 and phospho-Smad2 was low
and often undetectable in the pigmented junctional epithelium,
such as the mucocutaneous junction of the mouse eyelid where
pigmented melanocytes are abundantly located in the basal
layer of the epithelium (Figures S2Ab–S2Ae). Taken together,
the coincident expression patterns of TGF-b1/2 and phospho-
Smad2 in the stem cell niche suggest that TGF-b signaling is
Figure 3. Induction of Cell Cycle Arrest and
Maintenance of Undifferentiated Status by
TGF-b
(A) Percentage of cultured melanocytes at S/G2/M
phases. Primary cultured melanocytes were stim-
ulated with 4 pM TGF-b1 or 10 ng/ml SCF.
(B) TGF-b and SCF mutually balance melanocyte
cell numbers in a dose-dependent manner.
Primary cultured melanocytes were treated with
different concentrations of TGF-b1 and/or SCF.
The relative cell numbers for each condition are
shown.
(C) Percentage of large or dendritic melanocytes
(nonbipolar cells) with or without TGF-b1 treat-
ment of primary cultured melanocytes.
(D) Representative morphology of primary
cultured melanocytes in the presence or absence
of 4 pM TGF-b1.
(E) Representative appearance of DOPA-stained
melanocytes treated with TGF-b1 for 1 week.
(F) Appearance of melanocyte pellets after incuba-
tion of primary human melanocytes with TGF-b1
for one week.
(G) Tyrosinase activity of primary melanocytes
stimulated with TGF-b and 20 mM forskolin (FSK).
Data are presented as mean ± SD.
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Role for TGF-b in Melanocyte Stem Cell Maintenanceactive when melanocyte stem cells enter the dormant state and
maintain their immaturity.
TGF-b Induces Cell Cycle Arrest, Downregulation
of MITF, and Suppression of Melanogenic Genes
in Melanoblasts/Melanocytes
To examine the possible function of TGF-b in stem cell mainte-
nance, including the maintenance of stem cell immaturity and
the induction of stem cell dormancy in vivo, we tested the impact
of TGF-bs on melanocyte proliferation and differentiation in vitro.
First, we performed cell cycle analysis of primary cultured
melanocytes treated with TGF-b1/2. As shown in Figure 3A,
TGF-b induced a significant accumulation of cells in G1 and
a reduction of cells in S/G2M. Furthermore, the reduction by
TGF-b could be rescued by concomitant stimulation with SCF
(Kit ligand [KITL], a survival/mitogenic factor for the melanocyteCell Stem Cell 6, 130–140lineage), although SCF did not signifi-
cantly promote accumulation of cells in
S/G2M. The standard culture medium
used for primary melanocytes contains
TPA, which is essential for melanocyte
survival and proliferation in vitro. TPA
can be replaced by various melanocyte
survival factors including SCF, basic
fibroblast growth factor (bFGF), or endo-
thelin 1/3 (data not shown). SCF expres-
sion has been detected in follicular
keratinocyte stem cells of the bulge
area (Tumbar et al., 2004), the stem cell
niche for melanocyte stem cells. We
therefore examined potential interactions
of SCF with TGF-b on cell growth/
survival. As shown in Figure 3B, melano-cyte cell number was balanced by SCF and TGF-b in a dose-
dependent manner, with similar results seen in the tetrazolium
salt-based proliferation assay (WST assay) or by direct cell
counting. Melanocytes treated with TGF-b without any melano-
cyte survival/growth factors (such as SCF, endothelin1/3, or
bFGF) underwent apoptosis within 24–48 hr. Concomitant treat-
ment of melanocytes with those factors completely blocked
TGF-b1/2-induced apoptosis (Figure S3A). Melanoma cells,
most of which exhibit constitutively active MAPK because of
B-raf (Davies et al., 2002), N-ras (van ’t Veer et al., 1989), or
Kit (Chin et al., 2006; Curtin et al., 2006) mutations, were resis-
tant to TGF-b treatment (Figure S3B). Although multiple potential
mechanisms could account for TGF-b resistance in melanoma
cells, these data are consistent with the hypothesis that mela-
noma cells have escaped the physiologic role of TGF-b to
induce quiescence., February 5, 2010 ª2010 Elsevier Inc. 133
Figure 4. Downregulation of MITF and Its
Downstream Target Tyrosinase by TGF-b
(A) Western blotting for phospho-Smad2 after
stimulation of primary cultured human melano-
cytes with TGF-b1.
(B) Western blotting for MITF after TGF-b1 stimula-
tion.
(C) Tyrosinase expression is downregulated by
TGF-b1.
(D) Real-time PCR analysis of primary melano-
cytes after stimulation with TGF-b1. Data are pre-
sented as mean ± SD.
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Role for TGF-b in Melanocyte Stem Cell MaintenanceFunctional and Morphologic Consequences of TGF-b
During development, immature melanoblasts show character-
istic small and bipolar cell bodies rather than large dendritic
cell bodies (Nishimura et al., 1999). Melanocyte stem cells that
are entering the quiescent/inactivated state also show reduc-
tions in the number of dendrites and in the cell size (Figure 1).
Treatment of primary cultured melanocytes with TGF-b signifi-
cantly reduces the number of dendrites and the cell size and
produces a discretely bipolar morphology (Figures 3C and 3D),
so TGF-b might explain a set of melanocyte stem cell changes
including not only morphological changes but also downregula-
tion of melanogenic genes such as tyrosinase. Tyrosinase is
the rate-limiting enzyme involved in melanin synthesis, and its
activity is a marker for melanocyte differentiation. The dopa
reaction assay was utilized to assess tyrosinase activity in
primary melanocytes treated with TGF-b and other (control)
factors. The activity was examined with the same number of
viable melanocytes. As shown in Figures 3E and 3G, a significant
reduction of tyrosinase activity was detected after treatment
with TGF-b. An induction of tyrosinase activity was observed
with forskolin (FSK), as previously described (Suzuki et al.,
1997), and the effect of FSK was partially antagonized by
concomitant treatment with TGF-b. Furthermore, TGF-b treat-
ment maintained primary cultured melanocytes in an unpig-
mented state as shown in Figure 3F. These data suggest that
TGF-b downregulates tyrosinase, the critical and rate-limiting
enzyme for melanin synthesis, a specific marker for lineage
differentiation.
To examine how tyrosinase activity is inhibited by TGF-b
treatment, we studied the expression of phospho-Smad2 and
MITF, the transcriptional master regulator of the melanocyte
lineage. As shown in Figure 4, TGF-b induces Smad2 phos-
phorylation (Figure 4A) as well as the downregulation of
MITF protein expression (Figures 4B and 4C). Mitf mRNA
expression was also decreased significantly by 3 hr (Figure 4D).
Moreover, the downregulation of MITF protein expression
was associated with a reduction of downstream target gene134 Cell Stem Cell 6, 130–140, February 5, 2010 ª2010 Elsevier Inc.expression including tyrosinase (Fig-
ure 4C). Thus, the TGF-b induction of
cell cycle arrest, loss of dendricity, and
reduction in cell size and the functional
inactivation of the melanocyte lineage
are associated with the downregulation
of MITF and its downstream genes,
strongly suggesting important functionalroles of TGF-b in maintaining melanocyte stem cell immaturity
and quiescence.
Transforming Growth Factor b Receptor II Is a Key
Regulator of Melanocyte Stem Cell Maintenance
To examine the role of the TGF-b signaling pathway in the mela-
nocyte lineage, we bred TGFBRIIfx/fx mice (Cazac and Roes,
2000) to knockin mice expressing Cre recombinase under
control of the Dct promoter (Dctcre/cre knockin mice). These
mice were further bred with Dct-lacZ transgenic mice to tag
the melanocyte lineage cells. As shown in Figures 5A–5C,
TGFBRIIfx/fx;Dctcre/cre mice (cKO) exhibited mild but accelerated
hair graying (with 73.3% penetrance) within 10 months after
birth, whereas TGFBRII+/+;Dctcre/cre control mice (con) did not.
Histologically, the bulge area of midanagen hair follicles from
homozygous cKO mice began to show ectopically pigmented
melanocytes with dendritic morphologies starting from the
second hair cycle (Figures 5E, 5G, and 5I). These ectopically
differentiated melanocytes were preferentially found in follicles
that have pigmentation defects in the hair matrix (Figure 5K
and data not shown). Some of those follicles had completely
lost Dct-lacZ+ cells in the bulge area (Figures 5L and 5M), which
suggests that the melanocyte stem cells had prematurely
differentiated and were eventually depleted from the stem cell
niche. In contrast, Dct-lacZ+ melanoblasts are maintained in
the bulge area of control follicles in an immature and quiescent
state with small cell bodies and few dendrites in the bulge area
(Figures 5D, 5F, 5H, and 5J). Thus, these histological findings
suggest that melanocyte stem cells in cKO mice either failed to
return to quiescence (i.e., were slow to return to the quiescent
state undergoing premature differentiation in the niche) or alter-
natively that a defective stem cell progeny failed to migrate from
the bulge to the hair matrix. Because the dendritic melanocytes
in the bulge did not continue to accumulate in the bulge area with
age but rather were lost in follicles that had lost mature melano-
cytes in the hair matrix, the latter possibility was unlikely. This
phenotype of ectopically pigmented melanocytes (EPM) in the
Figure 5. Melanocyte Stem Cell Mainte-
nance through TGFbRII
Dctcre/cre; TGFBRIIfx/fx conditional knockout mice
(cKO) are compared to Dctcre/cre; TGFBRII+/+
(con) littermate controls.
(A–C) Images of hair coats of 6-month-old (A, B)
and 10-month-old (C) mice.
(D and E) Whole-mount lacZ staining of the trunk
skin from 3-month-old control (E) and TGFBRII
cKO mice with the Dct-lacZ transgene.
(E) Note that LacZ+ dendritic and slightly pig-
mented melanocytes with large cell bodies are
found in the bulge-subbulge area of late anagen
follicles in cKO mice (E, arrowheads), whereas
LacZ+ melanoblasts in the bulge area of control
follicles are immature and small in size (satisfying
the characteristic features of melanocyte stem
cells) (D, arrow). Deposition of melanin pigment
in the bulge area of cKO follicles (inset).
(F–K) Bright field images of LacZ-stained hair folli-
cles.
(F–I) In midanagen (anagen V) follicles, most LacZ+
melanoblasts in the bulge area of control follicles
are small in size with minimal dendrites (arrows
in F and H), whereas LacZ+ dendritic melanocytes
with large cell bodies (arrowheads in G and I)
instead of small melanoblasts were sometimes
found in the bulge area of cKO follicles at the
same stage of the hair cycle.
(J–L) Melanin incontinence was more frequently
found in the dermal papillae (asterisk) of cKO folli-
cles (K, L) than in control follicles (J) (3400). Sg,
sebaceous gland; Bg, bulge area.
(M) Statistical analysis of histological abnormali-
ties of hair follicle melanocytes in 6-month-old
cKO mice with the graying phenotype and in
control littermates. The frequency of hair follicles
with the typical histological abnormalities was
analyzed. Large and dendritic melanocytes or pig-
mented melanocytes in the bulge area of anagen
IV-VI follicles were classified as ‘‘abnormal’’ mela-
nocytes. Significance was evaluated by Student’s
t test. Data are presented as mean ± SEM.
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Role for TGF-b in Melanocyte Stem Cell Maintenancebulge resembles previous observations of rare pigmented mela-
nocytes in the niche in mice under genotoxic stress or in aging
wild-type mice, inMitfvit/vit mutant mice, and inCol17a1-deficient
mice (Nishimura et al., 2005; Inomata et al., 2009; and unpub-
lished data). In each case, ‘‘inappropriately’’ pigmented bulge
melanocytes preceded hair graying. Ectopic differentiation of
melanocyte stem cell progeny in the niche preceded the onset
of hair graying or occurred concomitantly with hair graying,
presumably because of the defective maintenance of stem cell
immaturity of melanocyte stem cells. Although the frequency of
the gray hairs was variable depending on the individual animal,
melanocyte stem cells had been lost in the bulge area of almost
all follicles that produced white hair. These phenomena
strongly suggest that stem cell-depleted follicles give rise to
white or gray hairs in the subsequent hair cycle. In contrast,
epidermal and dermal melanocytes in the pigmented junctional
epithelium, such as in mouse eyelids, are maintained both in
cKO mice and in control littermates (Figure S4). Collectively
these data suggest that the hair graying phenotype in the settingCof TGF-bRII deficiency can be caused by incomplete mainte-
nance of melanocyte stem cells.
Melanocyte Stem Cells Enter Quiescence
in a Bcl2-Dependent Manner by Responding
to Niche-Derived TGF-b
The antiapoptotic molecule Bcl2 is critical for melanocyte
stem cell entry into the dormant state of the hair follicle at around
stage 7 (i.e., postnatal days 6–7 for pelage hair follicles) (Nishi-
mura et al., 2005). As shown in Figure S6 and in our previous
report, lineage tracing studies revealed sudden and massive
loss of bulge melanocyte stem cells at stages 6–8 (Nishimura
et al., 2005). At this stage, TGF-b1/2 and phosphorylated
Smad2 start to be expressed in the stem cell niche as shown
in Figure 2. Thus, we hypothesized that TGF-b might be a trigger
for melanocyte stem cell apoptosis in the absence of Bcl2,
whereas TGF-b induces quiescence in wild-type melanocyte
stem cells. To test this possibility, an anti-TGF-b blocking anti-
body (1D11) (Dasch et al., 1989; Ling et al., 2003) or a matchedell Stem Cell 6, 130–140, February 5, 2010 ª2010 Elsevier Inc. 135
Figure 6. Treatment with an Anti-TGF-b
Neutralizing Antibody Promotes the
Survival of Bcl2 Null Melanocyte Stem Cells
at Their Entry into the Dormant State
(A–D) Stage 7 hair follicles on the dorsal skin of
wild-type mice treated with the control mono-
clonal antibody (mAb) (13C4) (A, C) or with the
anti-TGF-b neutralizing antibody (1D11) (B, D),
respectively, at days 4, 5, 6, and 7 after birth.
Asterisks show the nonspecific staining of the
cornified layer (X400). (C, D) Stage 4 hair follicles
on the ventral skin of animals (A) and (B), respec-
tively (3400).
(E–G) Images of whole-mount X-gal staining of
Bc2/ (F, G) and Bcl2/+ (E) mice with Dct-lacZ
transgene after treatment with the control
monoclonal antibody (13C4) (E, F) or with the
anti-TGF-b neutralizing antibody (1D11) (G),
respectively, at day 4, 5, 6, and 7 after birth. Bg,
bulge area; Sb, subbulge area.
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Role for TGF-b in Melanocyte Stem Cell Maintenancecontrol antibody (13C4) was injected into Bcl2/ mice during
the process of stem cell entry to the dormant state (stage 5–8
of hair follicle morphogenesis). First, we confirmed efficient
blocking of Smad2 phosphorylation with the TGF-b blocking
antibody but not with the control antibody by immunostaining
for phospho-Smad2 (Figures 6A–6D). Next, we examined the
viability of melanocyte stem cells in the bulge area of Bcl2/
mice and of control Bcl2/+ littermates. LacZ+ (transgenically
tagged) melanoblasts disappeared from the bulge area by P8
in Bcl2/ mice, either with or without the control antibody
(Figure 6F; Figure S5). Our prior studies demonstrated the pro-
grammed cell death of bulge melanoblasts at around P7 in
Bcl2 null mice. However, the viability of bulge LacZ+ melano-
blasts was preserved after administration of the TGF-b blocking
antibody in Bcl2/ mice at P4, P6, and P8 (Figure 6G). Because
the loss of bulge melanoblasts at P8 was such a synchronous,
high-penetrance feature of Bcl2/ mice, these data show
a dramatic rescue of the bulge melanoblast population upon
injection of the 1D11 TGF-b blocking antibody. In contrast,
mice treated with the control antibody appeared the same as
untreated Bcl2/ mice, with essentially complete melanoblast
loss at P8. It is noteworthy that melanocyte stem cells in Bcl2
null mice treated with 1D11 at P4, P6, and P8 were still absent
from whisker follicles, which develop earlier (during embryonic
development) than truncal follicles. Thus, the current findings
suggest that niche-derived TGF-b is critical not only for induction
of stem cell quiescence and maintenance of stem cell immatu-
rity, but also as a trigger of melanocyte stem cell apoptosis in
the setting of Bcl2 deficiency.
DISCUSSION
Melanocyte Stem Cell Entry into the Quiescent State
In this study, we demonstrate that TGF-b signaling is critical for
melanocyte stem cell entry/maintenance in the quiescent state.
The stem cell quiescence is preceded by the activation of
TGF-b signaling, the loss of Ki67 expression, the downregulation
of melanogenic gene expression, and dramatic morphologic136 Cell Stem Cell 6, 130–140, February 5, 2010 ª2010 Elsevier Inc.changes from a dendritic shape into a slender, oval shape with
shrinkage resulting from an increased nuclear/cytoplasmic ratio
(summarized in Figure 7). Upregulation of TGF-b1/2 expression
in the niche area and phospho-Smad2 expression by melano-
cyte stem cells was detected prior to morphological changes,
downregulation of melanogenic genes, and loss of Ki67 expres-
sion by melanocyte stem cells. These changes were found
during every hair cycle, which suggests that melanocyte stem
cells return to the quiescent state after completion of stem cell
division in early anagen. Although we previously reported that
Dct-lacZ-positive cells in the bulge area do not express tyrosi-
nase and are maintained in an immature state (Nishimura et al.,
2002), it was not clear at which stage melanocyte stem cells
lose tyrosinase expression and return to the quiescent state,
i.e., after localization in the niche or after stem cell division in
early anagen. In this study, we found that the expression of mel-
anogenic genes is significantly downregulated in melanocyte
stem cells at stages 6–8 as well as at midanagen stage during
hair cycle. Melanocyte stem cells divide only at early anagen
(Nishimura et al., 2002), so most melanocyte stem cells are
usually kept in a nondividing state—in the Go phase. This long
quiescent state gives rise to long-term in vivo labeling with
a nucleotide analog that is characteristically seen in a number
of somatic stem cells including the well-investigated hematopoi-
etic stem cells (Nystul and Spradling, 2006; Suda et al., 2005)
and epidermal stem cells (Cotsarelis et al., 1990; Tumbar et al.,
2004). Stem cell quiescence/dormancy is reminiscent of Caeno-
rhabditis elegans dauer formation, which promotes longevity
with minimum metabolism. Melanocyte stem cell quiescence
also might be a strategy for melanocyte stem cell longevity for
continuous hair pigmentation.
TGF-b Induces Melanoblast Immaturity through the
Downregulation of MITF and Its Downstream Targets
One of the core defining features of stemness is the maintenance
of an immature (undifferentiated) state. In melanocytes, the state
of differentiation is most clearly defined in relation to the pigmen-
tation pathway—a pathway that is potently regulated by the
Figure 7. Summary of Melanocyte Stem
Cell Status during the Hair Cycle
Dormant status (shown in blue) and activated
status (shown in red) of melanocyte stem cells
alternate in synchronization with the hair cycles.
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Role for TGF-b in Melanocyte Stem Cell Maintenancelineage selective transcription factor MITF (Steingrı´msson et al.,
2004; Levy et al., 2006). The studies reported here via primary
melanocytes demonstrate that TGF-b1/2 suppresses melanin
production as well as the activity of tyrosinase, the rate-limiting
melanogenic enzyme, and this is consistent with previously
reported observations in an immortalized cell line (Kim et al.,
2004). These effects can be explained by the downregulation
of Mitf, because tyrosinase and many other melanogenic genes
have been shown to be its direct downstream transcriptional
targets (Steingrı´msson et al., 2004; Vance and Goding, 2004;
Levy et al., 2006; Busca` and Ballotti, 2000; Lang et al., 2005).
Melanoblasts that have just colonized the melanocyte stem
cell niche do express tyrosinase. These cells lose the expression
of TGF-b within the TGF-b-expressing niche microenvironment,
suggesting that TGF-b inhibits the expression of melanogenic
genes to prevent melanocyte maturation.
TGF-b Signaling for Melanocyte Stem Cell Renewal
We previously observed a phenomenon that we presumptively
referred to as ‘‘in situ differentiation’’ or ‘‘ectopic differentiation’’
of melanocyte stem cells in midanagen follicles during the hair
graying process (Nishimura et al., 2005; Inomata et al., 2009).
A similar cell population was detected in the current study within
TGFbRII cKO mice. These ectopically pigmented melanocytes
(EPMs) in the niche are characterized by their dendritic, large
cell bodies and the production and accumulation of melanin
pigment in midanagen follicles. This phenomenon was observed
not only during aging but also in an accelerated fashion within the
graying mutant MITFvit/vit mice (Nishimura et al., 2005). In non-
aged physiological conditions, only immature melanoblasts
(melanocyte stem cells) can be found in the stem cell niche.
The accelerated appearance of EPMs in the setting of defec-
tive TGF-b signaling (i.e., in TGFBRII cKO mice) indicates that
TGF-b signaling plays an important role in the maintenance of
melanocyte stem cell immaturity. These changes were found
beginning at the second hair cycle, being distributed frequently
in midanagen follicles with defective hair pigmentation.
A role for TGF-b signaling in stem cell quiescence has
been previously suggested for hematopoietic stem cells, neural
stem cells, and prostate stem cells (Batard et al., 2000; Salm
et al., 2005; Larsson et al., 2003; Karlsson et al., 2007; FalkCell Stem Cell 6, 130–140et al., 2008; reviewed in Watabe and
Miyazono, 2009). Whereas TGFbRII is
dispensable for hematopoietic stem cell
renewal (Larsson et al., 2003), Smad4
is critical for stem cell renewal in the
hematopoietic system and in hair follicle
stem cells (Karlsson et al., 2007). TGFbRII
andSmad4 are also important for homeo-
stasis of the epidermis and hair follicles
(Guasch et al., 2007; Qiao et al., 2006;Yang et al., 2005, 2009). However, the role of TGF-b in
stem cell immaturity has not been previously implicated. Our
data demonstrate that TGF-b signaling is important for melano-
cyte stem cell renewal in TGFbRIIfx/fx; Dctcre/cre mice through
the maintenance of melanocyte stem cell immaturity and
quiescence.
There are some possible explanations for the gradual (rather
than abrupt) and partial loss of melanocyte stem cells observed
in the melanocyte-targeted TGFbRII-deficient mice (TGFbRIIfx/fx;
Dctcre/cre) studied. One possibility is that only a small fraction of
melanocyte stem cells (rather than the entire population)
becomes activated at the beginning of anagen. Indeed, a small
fraction of melanocyte stem cells can be labeled by the nucleo-
tide analog BrdU at the beginning of the anagen stage when
melanocyte stem cells undergo cell division. This suggests that
a small fraction of melanocyte stem cells are activated during
the hair cycle and only those activated melanocyte stem cells
need to go back into the quiescent state for self-renewal. Another
possibility is that the Cre recombination may not have completely
and homozygously deleted the floxed TGFbRII gene in all mela-
nocyte stem cells with a resultant incomplete penetrance of the
phenotype. In either case, the mild hair graying phenotype in
spite of the striking in vitro effects of TGF-b as well as the histo-
logical abnormalities observed in affected follicles of cKO mice
suggest compensatory mechanisms for the homeostatic regula-
tion of the melanocyte stem cell pool. The TGF-b signaling
pathway may be cooperating with other signals from the niche
cells as well as stem cells for stem cell maintenance/survival
and size control of the stem cell pool. Stem cells can renew them-
selves only when they survive and produce progeny that maintain
stem cell features. An antiapoptotic role of Dct /TRP2 also has
been reported (Nishioka et al., 1999; Chu et al., 2000; Pak et al.,
2004; Michard et al., 2008) but we have not observed any signif-
icant hair graying phenotype in Dctcre/cre mice (Guyonneau
et al., 2004). Based upon the in vitro and in vivo consequences
of TGF-b signaling on melanocytes, its effects in melanocyte
stem cells appear to include the induction of quiescence and
the maintenance of immaturity, which might be synergistically
promoted by other niche-specific environmental factors.
A separate function of TGF-b demonstrated in this study is the
induction of melanocyte stem cell apoptosis upon entry into, February 5, 2010 ª2010 Elsevier Inc. 137
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Role for TGF-b in Melanocyte Stem Cell Maintenancequiescence when Bcl2 is not functioning or under conditions of
growth/survival factor starvation. Phospho-Smad2 is detectable
in melanocyte stem cells when they return to the quiescent
state and the anti-TGF-b-blocking antibody blocks the expres-
sion and rescues Bcl2-deficient melanocyte stem cell death in
mice. These findings demonstrate that TGF-b is responsible for
the apoptosis of melanocyte stem cells in Bcl2 deficiency as
well as melanocyte stem cell maintenance. Thus TGF-b signaling
may alternatively determine quiescence versus death signaling,
depending upon the state of the Bcl2-related antiapoptotic
machinery downstream in the cells. Indeed, Bcl-2 protection of
cells from TGF-b-induced apoptosis has been reported (Huang
and Chou, 1998; Bruckheimer and Kyprianou, 2002). Thus,
such a mechanism of TGF-b-induced melanocyte stem cell
death could in principal contribute to certain instances of human
hair graying (e.g., in settings of insufficient local expression of
Bcl-2 or growth/survival factors).Relationship between Stem Cell Maintenance
and Melanomagenesis
Regional segregation of the melanocyte stem cell compartment
from the amplifying and differentiating compartment is quite
distinct within the hair follicle. Our data suggest that SCF and
TGF-b can balance the size of the melanocyte stem cell pool.
Bcl2, whose expression can be maintained by SCF via MITF
(McGill et al., 2002), is likely to be important in protecting against
TGF-b-induced apoptosis of melanocyte stem cells at stages
6–8, when they go into the quiescent state at the transition
from hair follicle morphogenesis to hair cycle progression.
These data are consistent with our previous findings that once
melanocyte stem cells enter dormancy (after colonization of
the stem cell niche in hair follicles), they survive in a manner
independent of KIT-blocking-antibody treatment (Nishimura
et al., 2002). Stem cell quiescence induced by TGF-b in the pres-
ence of Bcl2 might be necessary to obtain this KIT-independent
quiescence.
TGF-b signaling can induce either quiescence or apoptosis,
the latter occurring in Bcl2/ melanocytes or in wild-type
melanocytes deprived of serum growth factors in vitro. Cyto-
kines capable of activating a variety of receptor tyrosine
kinases potently protect against this TGF-b-induced death,
suggesting a potential mechanism for balancing the size of
the stem cell pool. Nearly all human melanocytic neoplasias
(including benign nevi) contain oncogenic mutations predicted
to constitutively activate the same pathway(s), in particular
mutations of KIT, B-RAF, and N-Ras (Davies et al., 2002; van ’t
Veer et al., 1989; Chin et al., 2006; Curtin et al., 2006). It will be
of interest to determine whether TGF-b signaling would be
antagonized by the actions of these mutations, comparable to
TGF-b antagonism by KIT signaling. If so, this could represent
a fundamental mechanism whereby such oncoproteins induce
growth/survival advantages to the melanocytic lineage within
these neoplasms.EXPERIMENTAL PROCEDURES
Animals and Antibody Teatment
Dct-lacZ transgenic mice (gift of Dr. I. Jackson) have been previously
described (Mackenzie et al., 1997; McGill et al., 2002; Nishimura et al.,138 Cell Stem Cell 6, 130–140, February 5, 2010 ª2010 Elsevier Inc.2002). The Dct-lacZ transgenic colony (CBA/C57BL6) was backcrossed to
C57BL/6J. Bcl-2/+ (C57BL/6J) and wild-type (C57BL/6J) mice were
purchased from the Jackson Laboratory or Charles River. TGFBRIIfx/fx (Cazac
and Roes, 2000),Dctcre/cre (Guyonneau et al., 2004), and Tyr-cre (Delmas et al.,
2003) have been described previously. A murine IgG1 monoclonal antibody,
1D11, which neutralizes all three mammalian TGF-b isoforms (1, 2, and 3),
was produced and purified at Genzyme Corporation (Framingham, MA). This
antibody has a circulatory half-life of 34 hr in mice when administered by intra-
peritoneal injection (Genzyme Corp.). An isotype-matched irrelevant murine
IgG1 monoclonal antibody, 13C4, also produced by Genzyme Corporation,
directed against Shigela toxin, was used as a control antibody. All animal
experiments were performed according to the Guidelines for the Care and
Use of Laboratory Animals and were approved by the Institutional Committee
of Laboratory Animal Experimentation (Kanazawa University and Dana-Farber
Cancer Institute).
Immunohistochemical Analysis
Immunohistochemical staining and whole-mount b-galactosidase staining
were performed as previously described (Nishimura et al., 2002, 2005; Inomata
et al., 2009). Additional details on the methods and antibodies used are
provided in the Supplemental Information.
Primary Melanocyte Culture
Primary human melanocytes from neonatal foreskins (provided by Dr. Ruth
Halaban, Yale University) were maintained between passages 1 and 4 in F10
medium containing (GIBCO-BRL), 7% fetal bovine serum, penicillin/strepto-
mycin/glutamine (GIBCO-BRL), 1 3 104 M 3-isobutyl-1-methyl xanthine
(IBMX)(Sigma), 50 ng ml1 12-O-tetradecanoyl phorbol-13-acetate (TPA,
Sigma), 1 mM Na3VO4, and 1 3 10
3 M N6,20-O-dibutyryladenosine 3:5-cyclic
monophosphate (dbcAMP, Sigma). A day before stimulation with TGF-b,
primary melanocytes were plated in medium containing a lower concentration
of TPA (10 ng ml1). For the Annexin V assay, the medium was replaced with
one supplemented with 10 ng ml1 TPA but without dbcAMP a day before
stimulation with TGF-b. Another source of primary human melanocytes (KUR-
ABO, Osaka, Japan) were maintained in medium254 (KURABO) supplemented
with 3 ng/ml recombinant bFGF, 5 mg/ml insulin, 0.18 mg/ml hydrocortisone,
10 ng/ml phorbol-12-myristate-13-acetate (PMA), 0.2% (v/v) bovine pituitary
extract (BPE), and 0.5% (v/v) fetal bovine serum (FBS) (KURABO). For the
Annexin V assay, the medium was replaced with one without dbcAMP and
bFGF a day before stimulation with TGF-b. Primary melanocytes were stimu-
lated with human TGF-b1 or TGF-b2 (R&D systems), 20 ng/ml recombinant
human SCF (R&D Systems), recombinant bFGF (Promega), 50 ng/ml TPA, or
20 mM Forskolin (Sigma).
Tyrosinase Assay
Enzymatic assays for tyrosinase (dopa oxidase) were performed according to
a published procedure (Modern Experimental Biochemistry) (Boyer, 1993) with
0.1 M phosphate buffer (pH 6.8) and 25 mM L-dopa (Sigma). Cells were trypsi-
nized and counted. The same number (3 3 105 for Figure 3G) of cells were
lysed with 1% TritonX/PBS at room temperature for 1 hr with shaking. Absor-
bance (475 nm) was analyzed with a multiplate reader (Bio Rad). The data were




The details on the methods are described in the Supplemental Information.
FACS Analysis for Annexin V Staining and Cell Cycle Analysis
Apoptosis was detected by Annexin V staining (BD PharMingen). Attached
and floating cells were harvested after 48 hr treatment with TGF-b and
other factors. Annexin V-FITC-positive cells were analyzed by FACS Caliber
(Becton Dickinson). For cell cycle analysis, cells were pelleted and fixed in
70% ethanol for 30 min. Cells were washed once with PBS and then were
stained with 1 mg/ml propidium iodide and 25 mg/ml RNase in PBS for
30 min. The cell cycle profiles were collected with FACS Caliber with Cellquest
(Becton Dickinson) and were analyzed with ModFit (Verity Software House)
software.
Cell Stem Cell
Role for TGF-b in Melanocyte Stem Cell MaintenanceCell Proliferation Assays
Viable cell counting with trypan blue staining and WST-1 cell proliferation
assays (Roche) were carried out to measure cell proliferation/viability accord-
ing to manufacturer’s instructions.Statistical Analysis
All experiments were performed with at least three different primary cultures or
animals in independent experiments. Significance was evaluated by Student’s
t test. Data are presented as mean ± SD or SEM, as indicated.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/
j.stem.2009.12.010.ACKNOWLEDGMENTS
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